Company news

Immuron Limited news in 2024

Immuron Limited's news releases, calls and decks from 2024, newest first.

View company

NMRC Reports Results for Campylobacter Clinical Study

October 4, 2024

Trading Halt

October 2, 2024

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

September 5, 2024

Appendix 4E and Preliminary Final Report

August 30, 2024

Immuron Travelan record sales globally, Australia and USA

July 14, 2024

IMM-529 pre-IND FDA filing

July 1, 2024

Immuron Travelan sales continued strong growth

April 9, 2024

Travelan to progress to Phase 3 Clinical Trials in the US

March 6, 2024

Immuron achieves record Travelan sales

February 12, 2024

Immuron achieves record half yearly Travelan sales

January 15, 2024

Decks in 2024